Trial NCT03030131

View at ClinicalTrials.gov 
Org. Study IDs: IFCT-1601

Last trial update was posted on 2023-03-14

MeSH Interventions

Durvalumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions


Stopping Reasons

Definitive discontinuation according to safety monitoring of death from the 46th patient onwards.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID